Relx PlcREL.L
What Relx Plc does.
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | £7.1B | £7.2B | £8.6B | £9.2B | £9.4B | £9.6B |
| Net income | £1.2B | £1.5B | £1.6B | £1.8B | £1.9B | £2.1B |
| Free cash flow | £1.6B | £2.0B | £2.4B | £2.4B | £2.6B | £2.8B |
More on REL.L.
- Relx Plc summary
- Relx Plc financial statements
- Relx Plc key metrics
- Relx Plc health scores
- Relx Plc valuation
- Relx Plc dividends
- Relx Plc peers
- Relx Plc annual reports
Figures from Relx Plc's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.